BioFire Diagnostics has secured FDA clearance for its FilmArray Blood Culture Identification, or BCID, panel, which the company says can detect more than 100 pathogens linked to sepsis. The device takes just about an hour to spot a pathogen in nine of 10 positive blood cultures and is meant to give hospitals a faster way to detect bloodstream infections.

Related Summaries